Fund Holdings — Pennant Investors, LP

Total Portfolio Value:
$366.26M
Total Bought:
$62.25M
Total Sold:
$63.42M
Net Transaction:
-$1.17M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Micron Technology, Inc.(MU)306,000431,000+125,000$36.07M$56.69M15.48%+$20.62M
Amazon.com, Inc.(AMZN)296,000240,000-56,000$53.39M$46.38M12.66%-$7.01M
TransDigm Group Incorporated(TDG)42,00032,371-9,629$51.73M$41.36M11.29%-$10.37M
EchoStar CorporationCL A(ECHO)2,153,2092,153,2090$30.68M$38.35M10.47%+$7.67M
Microsoft Corporation(MSFT)112,00080,000-32,000$47.12M$35.76M9.76%-$11.36M
Alphabet Inc.CL A(GOOG)199,000183,000-16,000$30.04M$33.33M9.10%+$3.30M
Antero Resources Corporation(AR)1,133,000836,000-297,000$32.86M$27.28M7.45%-$5.58M
Perimeter Solutions, Inc.(PRM)2,300,0002,300,0000$17.07M$18.01M4.92%+$943.0K
The Odp Corp400,000400,0000$21.22M$15.71M4.29%-$5.51M
Valmont Industries, Inc.(VMI)040,000+40,000$0$10.98M3.00%+$10.98M
GE Vernova Inc.(GEV)060,000+60,000$0$10.29M2.81%+$10.29M
Vertiv Holdings CoCL A(VRT)0115,000+115,000$0$9.96M2.72%+$9.96M
Iris Energy Ltd
ORDINARY SHARES
0470,000+470,000$0$5.31M1.45%+$5.31M
Core Scientific, Inc.(CORZ)0500,000+500,000$0$4.65M1.27%+$4.65M
Arcutis Biotherapeutics, Inc.(ARQT)170,900170,9000$1.69M$1.59M0.43%-$104.2K
Nurix Therapeutics, Inc.(NRIX)56,80056,8000$835.0K$1.19M0.32%+$350.5K
Novavax, Inc.(NVAX)60,30060,3000$288.2K$763.4K0.21%+$475.2K
Altimmune, Inc.(ALT)109,800109,8000$1.12M$730.2K0.20%-$387.6K
Fibrogen Inc768,400768,4000$1.81M$685.6K0.19%-$1.12M
Agios Pharmaceuticals, Inc.(AGIO)15,10015,1000$441.5K$651.1K0.18%+$209.6K
Fate Therapeutics, Inc.(FATE)146,100146,1000$1.07M$479.2K0.13%-$593.2K
Travere Therapeutics, Inc.(TVTX)055,800+55,800$0$458.7K0.13%+$458.7K
Enanta Pharmaceuticals, Inc.(ENTA)35,10035,1000$612.8K$455.2K0.12%-$157.6K
Igm Biosciences Inc64,90064,9000$626.3K$445.9K0.12%-$180.4K
Erasca, Inc.(ERAS)166,200166,2000$342.4K$392.2K0.11%+$49.9K
Arcus Biosciences, Inc.(RCUS)23,70023,7000$447.5K$361.0K0.10%-$86.5K
89bio Inc44,50044,5000$518.0K$356.4K0.10%-$161.5K
Zymeworks Inc.(ZYME)38,70038,7000$407.1K$329.3K0.09%-$77.8K
Arcturus Therapeutics Holdings Inc.(ARCT)13,10013,1000$442.4K$319.0K0.09%-$123.4K
Allogene Therapeutics Inc128,400128,4000$573.9K$299.2K0.08%-$274.8K
Coherus Oncology, Inc.(CHRS)168,100168,1000$401.8K$290.8K0.08%-$110.9K
Relay Therapeutics, Inc.(RLAY)42,40042,4000$351.9K$276.4K0.08%-$75.5K
Replimune Group, Inc.(REPL)30,50030,5000$249.2K$274.5K0.07%+$25.3K
uniQure N.V.SHS(QURE)48,50048,5000$252.2K$217.3K0.06%-$34.9K
Seres Therapeutics, Inc.(MCRB)292,300292,3000$226.3K$211.6K0.06%-$14.7K
Compass Therapeutics, Inc.(CMPX)199,000199,0000$394.0K$199.0K0.05%-$195.0K
Sage Therapeutics Inc17,50017,5000$327.9K$190.1K0.05%-$137.9K
Getaround Inc1,348,1531,348,1530$413.9K$188.7K0.05%-$225.1K
MacroGenics, Inc.(MGNX)43,80043,8000$644.7K$186.2K0.05%-$458.6K
Allakos Inc186,100186,1000$234.5K$186.1K0.05%-$48.4K
Allovir Inc215,700215,7000$162.8K$156.0K0.04%-$6.8K
Zentalis Pharmaceuticals, Inc.(ZNTL)32,40032,4000$510.6K$132.5K0.04%-$378.1K
BioXcel Therapeutics, Inc.(BTAIQ)83,90083,9000$236.6K$107.4K0.03%-$129.2K
Bluebird Bio Inc87,40087,4000$111.9K$86.0K0.02%-$25.9K
Grab Holdings LimitedW EXP 99 99 999
*W EXP 99/99/999
80,00080,0000$16.2K$12.9K0.00%-$3.3K
Agenus Inc.(AGEN)469,6000-469,600$272.4K$0—-$272.4K
Airspan Networks Holdings In1,047,4730-1,047,473$118.4K$0—-$118.4K
Enovis Corporation(ENOV)400,0000-400,000$24.98M$0—-$24.98M
Travere Therapeutics IncNOTE 2 500 9 155,8000-55,800$430.2K$0—-$430.2K
Page 1 of 1
Pennant Investors, LP — 13F Holdings — Q2 2024 | TickerTrail